Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporin and hydrocortisone eye drops in Sjögren syndrome dry eye
2017-004929-33Phase 4Completed
- Sponsor
- Klinik Hietzing
- Start
- Nov 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of cyclosporine in dry eye syndrome (DED), primary Sjögren's syndrome and Sjögren's syndrome, sponsored by Klinik Hietzing. Primary endpoint: Change in tear break-up time at 2 weeks. Started Nov 2018; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)primary Sjögren's syndromeSjögren's syndrome
Beyond the preview
Go deeper on 2017-004929-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004929-33.